Dr Flora Peyvandi
Dr Flora Peyvandi The Dacie /Wilkinson Bequest Lecture Wednesday 3rd April, 12:30- 13:15
Dr Flora Peyvandi
Dr. Peyvandi is Professor of Internal Medicine at the University of Milan and the Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy. Dr. Peyvandi received her medical degree from the University of Milan, Italy, is certified in Haematology and was awarded PhDs from the Maastricht University, The Netherlands and the University of Milan, Italy for her research in the field of rare bleeding disorders.
Dr Peyvandi's basic and medical science research has focussed on the investigation of coagulation disorders. Her research in the prevalence and mechanism of coagulation disorders has as its objective the development of cost effective treatment for the widespread treatment of patients. Previous research has encompassed genotype and phenotype studies of thrombotic and haemorrhagic disorders (arterial and venous thrombosis, haemophilia, von Willebrand disease, rare bleeding disorders – RBDs - and thrombotic microangiopathies). Dr. Peyvandi has contributed extensively to the study of RBDs which were rarely diagnosed and poorly characterised due to their low frequency. She has published extensively on this group of disorders and developed international registries with the aim of harmonising internationally the diagnosis and classification of RBDs. Similarly, she has set up an international collaboration on microangiopathies, rare thrombotic disorders, which can be difficult to diagnose and therefore treat. By coordinating a variety of studies Dr. Peyvandi has made the Milan centre one of the major contributors to research in the area of thrombotic thrombocytopenic disorders.Recently her research has been focused on the study of risk factors for the development of inhibitors in haemophilia and finally on the ‘next-generation’ DNA sequencing to understand the genetic predisposition to thrombotic and haemorrhagic disorders.
Dr. Peyvandi has authored and co-authored more than 400 scientific publications that have been published across well-known specialised journals (IF of about 1850, H index WoS of 55) and also 18 chapters in various books. Since 1999, she has been invited as an expert speaker at more than 140 national and international meetings and congresses. She has been the successful recipient of more than 40 project grants funded by Italian and International organisations.
She participates in clinical, educational and research activities in different parts of the world and she was Chair of the International Society of Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee on Factor VIII, Factor IX and Rare Coagulation Disorders. She is member of the ISTH council, member of the Executive Committee of the World Federation of Hemophilia (WFH), member of the executive committee of the European Association for Haemophilia and Allied Disorders (EAHAD) and member of the Medical Advisory Group of the European Hemophilia Consortium (EHC). In 2014 she was awarded the “Great Hippocrates " that is delivered to Italian medical researcher of the year.
Prof Dame Sally Davies
Prof Dame Sally Davis BSH Medal Lecture/Presidential session – The NHS beyond 70 years Tuesday 2nd April 11:00 – 12:45
Prof Dame Sally Davies
Dame Sally is the Chief Medical Officer for England and Chief Medical Advisor to the UK Government. She is an independent advisor to the UK Government on medical and public health matters.
Dame Sally founded the National Institute for Health Research and is a Non-Executive Director of Genomics England Ltd. She was a member of the WHO Executive Board and the Strategic and Technical Advisory Group on AMR. Most recently, she has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the UNGA 2016 declaration.
Dame Sally received her DBE in 2009, was elected Fellow of the Royal Society in 2014, and a member of the National Academy of Medicine, USA in 2015.